Publications by Dr Geoff Shenton - ePrints

Browsing publications by Dr Geoff Shenton.

Newcastle Authors	Title	Year
Dr Su Han Lum Dr Geoff Shenton Professor Sophie Hambleton Professor Andrew Gennery Professor Mary Slatter et al.	Alemtuzumab, Dual Graft-versus-Host Disease Prophylaxis, and Lower CD3+ T Cell Doses Equalize Rates of Acute and Chronic Graft-versus-Host Disease in Pediatric Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation with Matched Unrelated Donor Peripheral Blood Stem Cells or Bone Marrow Grafts	2024
Dr Zohreh Nademi Dr Geoff Shenton Helen Watson Emma Matthews Kay Carruthers et al.	CD3⁺TCRαβ/CD19⁺-depleted stem cell boost and CD45RO⁺ memory T-cell add-back as a successful salvage treatment for poor graft function unresponsive to eltrombopag, following a second allogenic HSCT	2024
Professor Marieke Emonts-le Clercq Ashley Bell Kathryn Bell Dr Daniel Fabian Professor John Isaacs et al.	Adeno-associated virus 2 infection in children with non-A–E hepatitis	2023
Dr Peter Carey Dr Scott Marshall Dr Geoff Shenton Dr Tina Biss Professor Roderick Skinner et al.	Allogenic haematopoeitic stem cell transplant as cure for severe transfusion-dependent non-dominant hereditary spherocytosis due to homozygous SPTA1 mutation	2023
Dr Frederik van Delft Professor Simon Bailey Professor Roderick Skinner Dr Geoff Shenton Dr Peter Carey et al.	Unusual relapse of low hypodiploid acute lymphoblastic leukaemia in a family with Li-Fraumeni syndrome	2023
Dr Hannah Tumelty Dr Geoff Shenton Dr Malcolm Brodlie	Are trough tobramycin concentrations taken from a central venous catheter accurate enough to safely use?	2022
Dr Tobias Menne Professor Julie Irving Professor Ruth Plummer Dr Geoff Shenton Professor Gareth Veal et al.	Selumetinib in combination with dexamethasone for the treatment of relapsed/refractory RAS-pathway mutated paediatric and adult acute lymphoblastic leukaemia (SeluDex): study protocol for an international, parallel-group, dose-finding with expansion phase I/II trial	2022